Molecular markers in ductal carcinoma in situ of the breast.

Published

Journal Article

Gene expression patterns in ductal carcinoma in situ (DCIS), and in invasive, and metastatic breast tumors were determined using serial analysis of gene expression (SAGE). We used mRNA in situ hybridization to examine gene expression at the cellular level and immunohistochemistry on tissue microarrays to determine association between gene expression patterns and histopathologic characteristics of the tumors. We found that that the most dramatic transcriptome change occurs at the normal to DCIS transition, while there is no clear universal "in situ" or "invasive" tumor molecular signature. From the 16,430 transcripts analyzed, we identified only 5 and 11 that were preferentially up-regulated in DCIS and invasive tumors, respectively. The majority of invasive cancer specific SAGE tags correspond to novel genes. The genes we identified may define biologically and clinically meaningful subgroups of DCIS with a high risk of progression to invasive disease.

Full Text

Duke Authors

Cited Authors

  • Porter, D; Lahti-Domenici, J; Keshaviah, A; Bae, YK; Argani, P; Marks, J; Richardson, A; Cooper, A; Strausberg, R; Riggins, GJ; Schnitt, S; Gabrielson, E; Gelman, R; Polyak, K

Published Date

  • March 2003

Published In

Volume / Issue

  • 1 / 5

Start / End Page

  • 362 - 375

PubMed ID

  • 12651909

Pubmed Central ID

  • 12651909

International Standard Serial Number (ISSN)

  • 1541-7786

Language

  • eng

Conference Location

  • United States